Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains
出版年份 2020 全文链接
标题
Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-08-17
DOI
10.1038/s41467-020-17920-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Monobodies as enabling tools for structural and mechanistic biology
- (2020) Oliver Hantschel et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
- (2019) Chin-Yap Loh et al. Frontiers in Oncology
- Targeted Protein Degradation through Cytosolic Delivery of Monobody Binders Using Bacterial Toxins
- (2019) Nadine Eliane Schmit et al. ACS Chemical Biology
- Allosteric modulation of a human protein kinase with monobodies
- (2019) Adelajda Zorba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients
- (2019) Gregorio Barilà et al. LEUKEMIA
- Direct Targeting Options for STAT3 and STAT5 in Cancer
- (2019) Anna Orlova et al. Cancers
- Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development
- (2018) Jacopo Sgrignani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
- (2018) Bettina Wingelhofer et al. LEUKEMIA
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Targeting interleukin-22 for cancer therapy
- (2018) Anamarija Markota et al. Human Vaccines & Immunotherapeutics
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies
- (2017) Tim Kükenshöner et al. JOURNAL OF MOLECULAR BIOLOGY
- Monobodies and other synthetic binding proteins for expanding protein science
- (2017) Fern Sha et al. PROTEIN SCIENCE
- Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase
- (2017) Sina Reckel et al. Nature Communications
- Targeting endogenous proteins for degradation through the affinity-directed protein missile system
- (2017) Luke J. Fulcher et al. Open Biology
- Canonical and Non-Canonical Aspects of JAK–STAT Signaling: Lessons from Interferons for Cytokine Responses
- (2017) Andrea Majoros et al. Frontiers in Immunology
- JAK-STAT signaling in cancer: From cytokines to non-coding genome
- (2016) Jan Pencik et al. CYTOKINE
- Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface
- (2016) John Wojcik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of RAS function through targeting an allosteric regulatory site
- (2016) Russell Spencer-Smith et al. Nature Chemical Biology
- Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
- (2016) Chengguang Zhao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Quantifying the dynamics of the oligomeric transcription factor STAT3 by pair correlation of molecular brightness
- (2016) Elizabeth Hinde et al. Nature Communications
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity
- (2015) Tiancen Hu et al. MOLECULAR AND CELLULAR BIOLOGY
- Transcriptional Regulation and Its Misregulation in Disease
- (2013) Tong Ihn Lee et al. CELL
- Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains
- (2013) F. Sha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expanding the Number of ‘Druggable’ Targets: Non-Enzymes and Protein-Protein Interactions
- (2012) Leah N. Makley et al. Chemical Biology & Drug Design
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis
- (2011) Florian Grebien et al. CELL
- The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3
- (2011) M. Vogt et al. JOURNAL OF CELL SCIENCE
- Teaching an Old Scaffold New Tricks: Monobodies Constructed Using Alternative Surfaces of the FN3 Scaffold
- (2011) Akiko Koide et al. JOURNAL OF MOLECULAR BIOLOGY
- STAT3 SIGNALING: Anticancer Strategies and Challenges
- (2011) P. A. Johnston et al. MOLECULAR INTERVENTIONS
- A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
- (2010) John Wojcik et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Role of STAT3 in In Vitro Transformation Triggered by TRK Oncogenes
- (2010) Claudia Miranda et al. PLoS One
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- New Activation Modus of STAT3
- (2009) Laure Dumoutier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- (2008) E. A. Nelson et al. BLOOD
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now